Every year, the world commemorates World Tuberculosis (TB) Day on 24 March to raise awareness of the impact of the disease for one’s health as well as social and economic consequences. ...
Every year, the world commemorates World Tuberculosis (TB) Day on 24 March to raise awareness of the impact of the disease for one’s health as well as social and economic consequences. ...
Johannesburg - The South African Health Products Regulatory Authority (SAHPRA) participated in the fourth edition of 2023 The Pharmacy Show (TPS) during 15-16 March 2023, at the Sandton Convention Centre. The Pharmacy Show is the leading networking and business event for everyone involved in supplying, marketing,...
KwaZulu-Natal - The South African Health Products Regulatory Authority (SAHPRA) has participated in the 36th Annual South African Association of Hospital and Institutional Pharmacists (SAAHIP) Annual Conference during 09 -11 March 2023, in KwaZulu-Natal. SAHPRA also had an opportunity to exhibit where information was shared...
1 March 2023 The COVID-19 pandemic turned the spotlight on the South African Health Products Regulator (SAHPRA), with many people expecting the regulator to approve medication that would see the end to the virus, but more often with limited understanding of the processes involved in reaching...
24 February 2023 The Radiation Control Unit of the South African Health Products Regulatory Authority (SAHPRA)hosted an engagement with Inspection Bodies. We have invited several Inspection Bodies to share their knowledge, experience, and expertise to begin this conversation focusing on the: Accreditation process by the South African National Accreditation...
Pretoria, 23 February 2023 - The South African Health Products Regulatory Authority (SAHPRA) hosted the Regional Quality Management Systems (QMS) Technical Working Group Workshop during 20 - 23 February 2023 at Protea Hotel – OR Tambo Airport. The participating countries included: Angola, Botswana, Eswatini, Lesotho,...
17 February 2023 Pretoria - The South African Health Products Regulatory Authority (SAHPRA) Radiation Control (RadCon) Unit has undergone intensive training on the Regulatory Authority Information System (RAIS+) through the International Atomic Energy Agency (IAEA). The training took place at the head office in Pretoria...
Pretoria, 30 January 2023 – The South African Health Products Regulatory Authority (SAHPRA) has registered Paxlovid, an anti-viral medicine manufactured by Pfizer, to treat COVID-19. Paxlovid, which contains Nirmatrelvir (150mg) and Ritonavir (100mg), is a medicine that is used for the treatment of mild to moderate...
09 January 2023 Note to Radionuclides Authority Holders The Annual Returns have been somewhat delayed and are now being sent out. It is a time-consuming process and will not be completed before 21 January 2023. Please await the prepopulated form for year-end 2022 (AR22) and do not resort...
